John D Doty MD
Critical Care Medicine, Pleural Disease
Medical Director of the Lung Cancer Screening Program for Early Detection and the Incidental Lung Nodule Program at Atrium Health
Join to view full profile
1237 Harding PlSte 3200Charlotte, NC 28204
Phone+1 704-355-5375
Fax+1 704-355-9241
Dr. Doty is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Doty is board certified in internal medicine, pulmonary disease and critical care medicine. He is currently the medical director of the Lung Cancer Screening Program and the Incidental Lung Nodule Program at Atrium Health. Dr. Doty performed the first endobronchial ultrasound procedure at Atrium Health Carolinas Medical Center and the first electromagnetic navigational bronchoscopy. He has been named a Charlotte Magazine Top Doctor for multiple years.
Education & Training
Medical University of South CarolinaFellowship, Pulmonary Disease and Critical Care Medicine, 2001 - 2004
University of Tennessee College of MedicineResidency, Internal Medicine/Pediatrics, 1996 - 2000
University of Tennessee Health Science Center College of MedicineClass of 1996
Certifications & Licensure
SC State Medical License 2002 - 2027
NC State Medical License 2007 - 2026
TN State Medical License 1998 - 2008
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Powerchart, Cerner Healthe and IQHealth, Cerner Corporation, 2012, 2014
- CMS Meaningful Use Stage 1 Certification PowerChart, Cerner Healthe, IQHealth, HealthSentry and P2 Sentinel, Cerner Corporation, 2012, 2014
- CMS Meaningful Use Stage 1 Certification PowerChart, Cerner Healthe, Cerner Patient Portal, HealthSentry and P2 Sentinel, Cerner Corporation, 2012, 2014
Publications & Presentations
PubMed
- 238 citationsTreatment of Sarcoidosis With InfliximabJohn D. Doty, Joseph E Mazur, Marc A. Judson
Chest. 2005-03-01 - 29 citationsFatality related to a 30-g venlafaxine overdose.Joseph E Mazur, John D. Doty, Ashley S. Krygiel
Pharmacotherapy. 2003-12-01 - 91 citationsTreatment of corticosteroid-resistant neurosarcoidosis with a short-course cyclophosphamide regimen.John D. Doty, Joseph E Mazur, Marc A. Judson
Chest. 2003-11-01
Press Mentions
‘We Are Very, Very Cautious’: What Endemic COVID May Look like for High-Risk PeopleJanuary 22nd, 2022- Atrium Health Doctors Use Artificial Intelligence and Robots to Help Detect Lung Cancer EarlyJune 18th, 2021
- New Robot and Software Help Diagnose Lung CancerJune 15th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
